Quick Links:
Back to Home Page Back to Warrant Sheets
Back to Expired Warrants
Warrant Symbol - TBP.WT.C
Tetra Bio-Pharma
warrants to list on TSX-V Feb.
25
Tetra Bio-Pharma closes
$8.05-million unit offering
Address: 200 - 2742 St
Joseph Blvd
Orleans Ont Canada K1C 1G5
Phone: 343 689 0714 Fax: 343 689
0716
Web Site:
https://tetrabiopharma.com
Number Trading - 61,329,744
Expiration Date -
March 2, 2024
Cusip - 88166Y 16 7 Exercise Price - $0.28
Warrant Symbol - TBP.WT.B
Number Trading - 33,632,095
Expiration Date - February 13, 2023
Cusip - 88166Y 13 4
Exercise Price - $0.75
Warrant Symbol - TBP.WT.A
Number Trading - 26,833,332
Expiration Date - July 12, 2022,
Cusip - 88166Y 12 6
Exercise Price - $0.40
Warrant Symbol - TBP.WT
Number Trading - 11.5 million
Expiration Date - March 5, 2021
Cusip - 88166Y 11 8
Exercise Price - $1.30
Warrants called to trade news:
Tetra
Bio-Pharma warrants to trade on TSX March 2
2021-03-01 19:58 ET - Warrants Called to Trade
The Toronto Stock Exchange reports that Tetra
Bio-Pharma Inc. will list up to 57 million
common share purchase warrants for trading on
the TSX at the open on March 2, 2021.
According to the TSX, the warrants will trade
under the symbol TBP.WT.C, in Canadian dollars
and under Cusip No. 88166Y 16 7.
As stated in its prospectus supplement dated
Feb. 24, 2021, the company will issue up to 57
million units at 22 cents per unit in an
offering. Each unit will consist of one common
share and one warrant of the company, with
each warrant being exercisable at 28 cents per
share until 5 p.m. Toronto time on the date
that is 36 months after the closing date of
the offering.
© 2022 Canjex Publishing Ltd. All rights
reserved.
2020-02-20 15:44 MT - News
Release
A total of 31,292,471 common
share purchase warrants of Tetra
Bio-Pharma Inc. will be listed
and posted for trading under the
symbol TBP.WT.B on the TSX
Venture Exchange, effective on
or about Feb. 25, 2020.
The warrants were issued in
connection with the
corporation's bought deal
prospectus offering of units
that closed on Feb. 13, 2020.
Each unit consisted of one
common share and one warrant.
Each warrant entitles the holder
thereof to purchase one common
share at an exercise price equal
to 75 cents at any time before
Feb. 13, 2023. The warrants to
be listed on the TSX Venture
Exchange also include a total of
2,047,171 warrants which were
issued to Echelon Wealth
Partners Inc. as compensation
for its services as underwriter
for the offering, as described
in the corporation's final
short-form prospectus dated Feb.
6, 2020.
2020-02-20 15:44 MT - News Release
Offering: The offering consists
in a minimum number of
16,666,667 units and a maximum
number of 23,333,333 units at
the price of 30 cents per unit.
Each unit consists of one common
share and one common share
purchase warrant. Each warrant
entitles the holder to purchase
one additional common share at
the exercise price of 40 cents
per share during a period of 36
months following the closing
date.
Capitalization: 26,833,332
warrants issued and outstanding
Warrant exercise price: 40 cents
per share at any time prior to 5
p.m. Toronto time on the date
that is 36 months following the
closing date of the offering
(The expiry date of the warrants
is July 12, 2022, in the warrant
indenture.)
Trading symbol: TBP.WT.A
Cusip No.: 88166Y 12 6
The warrants were issued
pursuant to a prospectus dated
July 8, 2019, for a total
proceeds of $8,049,999.60
(26,833,332 units at 30 cents
per unit). Each unit consists of
one common share and one
warrant. Each warrant entitles
the holder to purchase one
common share of the Company at a
price of 40 cents per common
share until July 12, 2022.)
© 2019 Canjex Publishing Ltd.
All rights reserved.
Tetra Bio-Pharma
warrants list on TSX-V
2018-05-30 14:51 MT - Warrants
Called to Trade
Effective at the opening on
Friday, June 1, 2018, the share
purchase warrants of the company
will commence trading on the TSX
Venture Exchange.
Trading symbol: TBP.WT
Cusip No.: 88166Y 11 8
The warrants were issued
pursuant to the short form
prospectus offering dated Feb.
26, 2018, of total proceeds of
$11.5-million (11.5 million
units at $1 per unit) that was
accepted for filing on May 25,
2018. Each unit comprises one
common share and one common
share purchase warrant. Each
warrant entitles the holder to
purchase one additional common
share at the exercise price of
$1.30 per share until March 5,
2021.
© 2018 Canjex Publishing Ltd.
All rights reserved.